サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1561570

羊膜市場レポート：製品、用途、エンドユーザー、地域別、2024年～2032年

Amniotic Membrane Market Report by Product, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
羊膜市場レポート：製品、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の羊膜市場の市場規模は2023年に15億米ドルに達しました。今後、IMARC Groupは、2024年から2032年の間に8％の成長率（CAGR）を示し、市場は2032年までに32億米ドルに達すると予測しています。低侵襲（MI）治療への嗜好の高まり、糖尿病や関節リウマチのような慢性疾患の有病率の上昇、専門クリニックや病院の拡大は、市場を推進する主な要因の一部です。

羊膜は胎盤の最内層で、厚い基底膜と無血管間質マトリックスからなります。羊膜は胎盤に由来する生体組織で、そのユニークな特性から医療用途に利用されています。炎症反応を調節することで炎症を抑え、組織の線維化や瘢痕化を最小限に抑えます。痛みを伴う創傷や火傷に鎮静効果を与え、治癒時間を短縮します。安全で忍容性が高く、拒絶反応も少ないため、角膜潰瘍などの眼表面障害の手術に広く使用されています。また、癒着を軽減し回復を促進するための生物学的ドレッシング材としても使用されています。

低侵襲（MI）治療への嗜好の高まりが、様々な外科手術における羊膜の利用を増加させています。さらに、ヘルスケアインフラの成長と専門クリニックや病院の拡大は、羊膜治療の実施に多くの機会を提供しています。これとは別に、様々な大手市場プレーヤーは、リーチを拡大し、専門知識を共有し、新たな市場にアクセスするためにM&A（合併・買収）に注力しています。さらに、企業は積極的に製品ラインを多様化し、様々な外科的・治療的ニーズに合わせた羊膜を提供しています。さらに、いくつかの国の政府は、羊膜の利点と用途についてヘルスケア専門家と患者を教育する努力を強めており、これは良好な市場見通しを提供しています。

羊膜市場動向/促進要因：

再生医療への需要の高まり

糖尿病や関節リウマチのような慢性疾患の有病率が上昇し、慢性的な創傷や潰瘍につながることから、効果的な治療法の必要性が高まっています。羊膜は革新的なソリューションを提供し、治癒プロセスを刺激します。これとは別に、様々な健康状態に罹患しやすい世界の老人人口の増加が、より早い治癒と組織再生を促進する治療の必要性を高めています。さらに、整形外科や歯科医学のような様々な医療専門分野で羊膜の採用が増加していることも、市場にプラスの影響を与えています。さらに、細胞の成長を促進し炎症を抑える羊膜の能力は、他の再生治療における羊膜の採用を促進しています。

医療処置における技術の進歩

先端技術の統合により、効率と効能が向上した羊膜が開発されています。最新の技術により、必要不可欠な成長因子と治癒特性が確実に維持され、様々な医療領域での適用性が高まっています。羊膜は幹細胞治療や三次元（3D）バイオプリンティングのような最先端治療との適合性があり、有利な市場展望を提供しています。これらの統合は、より個別化された効果的な治療を可能にし、患者ケアの質を高める。これとは別に、保存方法の改善により、より長い保存期間と幅広い流通が可能になり、様々な地域やヘルスケアシステムでの採用が増加しています。

支持的な規制環境

各国の規制機関は羊膜の治療的価値を認識し、羊膜の抽出、加工、保存、適用に関する明確で明確なガイドラインを実施しています。これらのガイドラインは実務の均一性を保証し、製品の品質を維持します。これとは別に、規制当局はすべての関連規則と基準の遵守を確保するため、市場を積極的に監視しています。定期的な検査、監査、報告要件は、業界の信頼と誠実さの維持に役立っています。さらに、この分野の研究開発を奨励する助成金、奨励金、官民パートナーシップを含む支援政策を提供しています。研究機関との協力的な取り組みは、イノベーションを推進し、斬新な製品や治療法を市場に送り出すことができます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の羊膜市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 凍結保存羊膜
    • 市場動向
    • 市場予測
  • 凍結乾燥羊膜
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 手術創
    • 市場動向
    • 市場予測
  • 眼科
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • 専門クリニック
    • 市場動向
    • 市場予測
  • 研究センターと研究所
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Amnio Technology LLC
    • Amniox Medical Inc.（TissueTech Inc.）
    • Genesis Biologics
    • Human Regenerative Technologies LLC
    • Integra LifeSciences Holdings Corporation
    • Katena Products Inc.
    • MiMedx Group
    • Next Biosciences
    • Skye Biologics Holdings LLC
    • Smith & Nephew plc
    • Surgenex LLC
    • Ventris Medical LLC
    • Wright Medical Group N.V.（Stryker B.V.）
図表

List of Figures

  • Figure 1: Global: Amniotic Membrane Market: Major Drivers and Challenges
  • Figure 2: Global: Amniotic Membrane Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Amniotic Membrane Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Amniotic Membrane Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Amniotic Membrane Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Amniotic Membrane Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Amniotic Membrane Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Amniotic Membrane (Surgical Wounds) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Amniotic Membrane (Surgical Wounds) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Amniotic Membrane (Ophthalmology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Amniotic Membrane (Ophthalmology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Amniotic Membrane (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Amniotic Membrane (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Amniotic Membrane (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Amniotic Membrane (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Amniotic Membrane (Specialized Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Amniotic Membrane (Specialized Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Amniotic Membrane (Research Centers and Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Amniotic Membrane (Research Centers and Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Amniotic Membrane Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Amniotic Membrane Industry: SWOT Analysis
  • Figure 76: Global: Amniotic Membrane Industry: Value Chain Analysis
  • Figure 77: Global: Amniotic Membrane Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Amniotic Membrane Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Amniotic Membrane Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Amniotic Membrane Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Amniotic Membrane Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Amniotic Membrane Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Amniotic Membrane Market: Competitive Structure
  • Table 7: Global: Amniotic Membrane Market: Key Players
目次
Product Code: SR112024A4503

The global amniotic membrane market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 8% during 2024-2032. The increasing preference for minimally invasive (MI) treatments, rising prevalence of several chronic conditions like diabetes and rheumatoid arthritis, and the expansion of specialized clinics and hospitals are some of the major factors propelling the market.

The amniotic membrane is the innermost layer of the placenta, which consists of a thick basement membrane and an avascular stromal matrix. It is a biological tissue derived from the placenta and utilized in medical applications due to its unique properties. It reduces inflammation by modulating inflammatory responses and minimizes fibrosis and scarring in tissues. It provides a soothing effect on painful wounds and burns and reduces their healing times. It is safe and well-tolerated, with low rejection rates and widely used in surgeries for ocular surface disorders, such as corneal ulcers. It is also employed as a biological dressing to reduce adhesions and enhance recovery.

The increasing preference for minimally invasive (MI) treatments is resulting in the increasing utilization of the amniotic membrane in various surgical procedures. Additionally, growth in healthcare infrastructure and the expansion of specialized clinics and hospitals are offering more opportunities for the implementation of amniotic membrane therapies. Apart from this, various leading market players are focusing on mergers and acquisitions (M&A) to expand their reach, share expertise, and access new markets. Furthermore, companies are actively diversifying their product lines, offering amniotic membranes tailored for various surgical and therapeutic needs. Moreover, governments of several countries are increasing their efforts to educate healthcare professionals and patients about the benefits and applications of amniotic membranes, which is offering a favorable market outlook.

Amniotic Membrane Market Trends/Drivers:

Increasing demand for regenerative medicine

The rising prevalence of several chronic conditions like diabetes and rheumatoid arthritis, leading to chronic wounds and ulcers is increasing the need for effective treatment methods. Amniotic membranes offer an innovative solution and stimulate the healing process. Apart from this, the growing global geriatric population, which is highly susceptible to various health conditions is driving the need for treatments that promote faster healing and tissue regeneration. Furthermore, the increasing adoption of amniotic membranes in various medical specialties like orthopedics and dental medicine is positively influencing the market. Moreover, the ability of the amniotic membrane to facilitate cellular growth and decrease inflammation is driving its adoption in other regenerative treatments.

Technological advancements in medical procedures

The integration of advanced technologies is resulting in the development of amniotic membranes with increased efficiency and efficacy. Modern techniques ensure that essential growth factors and healing properties are maintained, enhancing their applicability in various medical domains. The compatibility of the amniotic membrane with cutting-edge treatments, such as stem cell therapies and three-dimensional (3D) bioprinting, is offering a favorable market outlook. These integrations allow for more personalized and effective treatments and enhance the quality of patient care. Apart from this, improved preservation methods allow for longer shelf life and wider distribution, which is increasing its adoption across various regions and healthcare systems.

Supportive regulatory environment

Regulatory bodies of various countries are recognizing the therapeutic value of the amniotic membrane and implementing clear and well-defined guidelines for the extraction, processing, preservation, and application of amniotic membranes. These guidelines ensure uniformity in practices and uphold the quality of products. Apart from this, regulatory authorities are actively monitoring the market to ensure compliance with all relevant rules and standards. Regular inspections, audits, and reporting requirements help maintain trust and integrity in the industry. Furthermore, they are offering supportive policies, which include grants, incentives, and public-private partnerships that encourage research and development in the field. Collaborative efforts with research institutions can drive innovation and bring novel products and therapies to market.

Amniotic Membrane Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global amniotic membrane market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Cryopreserved Amniotic Membrane
  • Lyophilization Amniotic Membrane

Cryopreserved amniotic membrane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes cryopreserved amniotic membrane and lyophilization amniotic membrane. According to the report, cryopreserved amniotic membrane represented the largest segment.

It has a long shelf life and it allows hospitals and clinics to maintain an inventory without the risk of degradation. It also offers ease of storage, simplifies logistics, and reduces waste. Additionally, it aids in maintaining the biological integrity of the amniotic membrane and enhancing the therapeutic effectiveness of the membrane. This ability to retain the natural healing properties is attracting healthcare providers. Apart from this, regulatory bodies are recognizing the benefits of cryopreservation and are actively providing supportive guidelines and approvals. This support from regulatory authorities is promoting the adoption of cryopreserved amniotic membranes across different regions.

Breakup by Application:

  • Surgical Wounds
  • Ophthalmology
  • Others

Surgical wounds account for the majority of the market share

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes surgical wounds, ophthalmology, and others. According to the report, surgical wounds hold the majority of the market share. Increasing road accidents and major sports injuries are leading to a rise in elective and emergency surgeries across various medical disciplines, which is catalyzing the need for effective wound care. Additionally, technological advancements in surgical procedures are allowing for more complex and numerous surgeries to be performed with optimal efficiency. Apart from this, the rising focus on minimizing post-operative infections and complications is driving the demand for high-quality wound care products. The growing awareness about the importance of infection prevention and control is encouraging healthcare providers and patients to opt for optimal wound care solutions. Furthermore, rising preferences for effective healing without significant scarring is leading to innovations in wound care products specifically designed for surgical wounds.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers and Laboratory

Hospitals hold the largest share of the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, specialized clinics, and research centers and laboratory. According to the report, hospitals accounted for the largest market share. They have specialized medical professionals and skilled staff trained to deal with various medical conditions. They can offer enhanced diagnostic and therapeutic procedures as they are equipped with technologically advanced medical equipment. Apart from this, they provide emergency medical services and handle urgent and life-threatening situations, which is offering a favorable market outlook. Furthermore, many hospitals have established relationships with insurance providers, facilitating easier and more comprehensive coverage for patients, which makes hospital-based care more accessible for many individuals. Moreover, hospitals in various regions receive government funding and support, which ensures the availability of essential healthcare services to the wider population.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest amniotic membrane market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share since the region is home to leading research institutions and biotechnology companies that actively invest in the research and development (R&D) activities of regenerative medicine, including amniotic membranes. Additionally, the region has a highly developed healthcare system with state-of-the-art facilities and technology, which drives innovation and facilitates the adoption of advanced medical products, such as amniotic membranes. Apart from this, supportive regulatory guidelines for the development, approval, and use of amniotic membrane products in North America is encouraging manufacturers to expand their market reach. Furthermore, collaborations between hospitals, research institutions, and biotechnology companies is enhancing innovation and market penetration in the region.

Competitive Landscape:

Companies are currently engaging in a variety of activities to expand the scope and efficiency of this unique biological material. They are extracting the amniotic membrane from the placenta and are processing it under carefully controlled conditions. Additionally, they are conducting rigorous R&D, exploring new possibilities for amniotic membrane use in regenerative medicine. Apart from this, they are working continuously to enhance the potential of the amniotic membrane, improving the prospects of new therapies, and continuing to support the broader goals of healthcare and patient well-being. Furthermore, many companies are actively involved in educating healthcare providers about the benefits and applications of the amniotic membrane.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Amnio Technology LLC
  • Amniox Medical Inc. (TissueTech Inc.)
  • Genesis Biologics
  • Human Regenerative Technologies LLC
  • Integra LifeSciences Holdings Corporation
  • Katena Products Inc.
  • MiMedx Group
  • Next Biosciences
  • Skye Biologics Holdings LLC
  • Smith & Nephew plc
  • Surgenex LLC
  • Ventris Medical LLC
  • Wright Medical Group N.V. (Stryker B.V.).

Recent Developments:

  • In February 2022, Amnio Technology LLC launched two new PalinGen membrane products, PalinGen Dual-Layer Membrane and Dual Layer PalinGen X-Membrane. They are minimally manipulated, homologous use and chorion-free.
  • In June 2021, MiMedx Group received reimbursement approval in Japan, making it the first and only amniotic tissue product approved for use in the country.

Key Questions Answered in This Report

  • 1. What was the size of the global amniotic membrane market in 2023?
  • 2. What is the expected growth rate of the global amniotic membrane market during 2024-2032?
  • 3. What are the key factors driving the global amniotic membrane market?
  • 4. What has been the impact of COVID-19 on the global amniotic membrane market?
  • 5. What is the breakup of the global amniotic membrane market based on the product?
  • 6. What is the breakup of the global amniotic membrane market based on the application?
  • 7. What is the breakup of the global amniotic membrane market based on the end user?
  • 8. What are the key regions in the global amniotic membrane market?
  • 9. Who are the key players/companies in the global amniotic membrane market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Amniotic Membrane Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cryopreserved Amniotic Membrane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lyophilization Amniotic Membrane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Surgical Wounds
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ophthalmology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialized Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Research Centers and Laboratory
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amnio Technology LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Amniox Medical Inc. (TissueTech Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Genesis Biologics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Human Regenerative Technologies LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Integra LifeSciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Katena Products Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 MiMedx Group
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Next Biosciences
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Skye Biologics Holdings LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Smith & Nephew plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Surgenex LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Ventris Medical LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Wright Medical Group N.V. (Stryker B.V.)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 SWOT Analysis